Association of child weight and adverse outcomes following antibiotic prescriptions in children: a national data study in Wales, UK
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
Yn: BMJ paediatrics open, Cyfrol 8, Rhif 1, 28.11.2024.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
APA
CBE
MLA
VancouverVancouver
Author
RIS
TY - JOUR
T1 - Association of child weight and adverse outcomes following antibiotic prescriptions in children
T2 - a national data study in Wales, UK
AU - Opatola, Ayodele Vincent
AU - Seaborne, Mike J
AU - Kennedy, Jonathan
AU - Hughes, Dyfrig
AU - Laing, Hamish
AU - Owen, Rhiannon K
AU - Tuthill, David
AU - Bracchi, Robert
AU - Brophy, Sinead
N1 - © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.
PY - 2024/11/28
Y1 - 2024/11/28
N2 - OBJECTIVE: To examine if the weight of a child determines adverse events following oral antibiotics prescription.DESIGN: Population respective cohort using linked general practice (GP), hospital data and linkage with the Welsh Demographic Service for demographic information. Data linkage was performed using Wales health data, extracted from the SAIL (Secure Anonymised Information Linkage) databank.INCLUSION: Children (0-12 years) prescribed oral antibiotics by their GP in Wales.EXPOSURE: Antibiotic prescription (penicillins, cephalosporins, macrolides, dihydropyrimidines, nitroimidazoles, nitrofurans, lincosamides).OUTCOME: Adverse event as defined by; patients' death within 5 days, records of emergency admission within 5 days and GP records of adverse drug reactions or prescription of another antibiotic within 14 days.ANALYSIS: Logistic regression of adverse events versus no adverse events at follow-up time.RESULTS: There were 139 571 prescriptions of the selected antibiotics and 71 541 children (51.39% male) included with follow-up data of which there were 25 445 (18.23% of all prescriptions) children experienced adverse outcomes. There was higher odds of adverse events for lower weight children and those who were younger, female, of Asian origin or deprived.CONCLUSION: The findings support the hypothesis that smaller children for their age (eg, low weight, female, Asian) are more likely to experience adverse events following antibiotics prescription. This work suggests child weight, in addition to age, should be used when prescribing antibiotics to children in primary care.
AB - OBJECTIVE: To examine if the weight of a child determines adverse events following oral antibiotics prescription.DESIGN: Population respective cohort using linked general practice (GP), hospital data and linkage with the Welsh Demographic Service for demographic information. Data linkage was performed using Wales health data, extracted from the SAIL (Secure Anonymised Information Linkage) databank.INCLUSION: Children (0-12 years) prescribed oral antibiotics by their GP in Wales.EXPOSURE: Antibiotic prescription (penicillins, cephalosporins, macrolides, dihydropyrimidines, nitroimidazoles, nitrofurans, lincosamides).OUTCOME: Adverse event as defined by; patients' death within 5 days, records of emergency admission within 5 days and GP records of adverse drug reactions or prescription of another antibiotic within 14 days.ANALYSIS: Logistic regression of adverse events versus no adverse events at follow-up time.RESULTS: There were 139 571 prescriptions of the selected antibiotics and 71 541 children (51.39% male) included with follow-up data of which there were 25 445 (18.23% of all prescriptions) children experienced adverse outcomes. There was higher odds of adverse events for lower weight children and those who were younger, female, of Asian origin or deprived.CONCLUSION: The findings support the hypothesis that smaller children for their age (eg, low weight, female, Asian) are more likely to experience adverse events following antibiotics prescription. This work suggests child weight, in addition to age, should be used when prescribing antibiotics to children in primary care.
KW - Humans
KW - Female
KW - Child, Preschool
KW - Wales/epidemiology
KW - Male
KW - Infant
KW - Anti-Bacterial Agents/adverse effects
KW - Child
KW - Body Weight/drug effects
KW - Infant, Newborn
KW - Drug Prescriptions/statistics & numerical data
KW - Logistic Models
KW - Administration, Oral
U2 - 10.1136/bmjpo-2024-002831
DO - 10.1136/bmjpo-2024-002831
M3 - Article
C2 - 39613399
VL - 8
JO - BMJ paediatrics open
JF - BMJ paediatrics open
SN - 2399-9772
IS - 1
ER -